J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the ...

J&J faces lawsuits from more than 62,000 claimants who alleged that its baby powder and other talc products were ... the legitimate claims of ovarian cancer victims,” Birchfield said.

If approved, the settlement may resolve nearly 60,000 talcum powder claims for ovarian cancer. In Connecticut, a jury ordered Johnson & Johnson to pay $15 Million to Evan Plotkin, who was diagnosed ...

Ovarian cancer can affect anyone born with female reproductive organs including the ovaries and fallopian tubes. This includes women, transgender men and non-binary people. We don’t know what causes ...

umontreal.ca Objectives To investigate employment in an occupation or industry and specific occupational exposures in relation to ovarian cancer risk ... versus never exposure to 18 agents: cosmetic ...

A diagnosis of ovarian cancer carries a dual threat—the disease itself and the danger of the cancer spreading. Now new research has uncovered a crucial factor, leader cells, that is a key to both.

Ovarian cancer actually refers to several different types of cancer-- more than 30, in fact. The types of ovarian cancer are grouped by the kind of cell where they start. Your ovaries have three ...

Company attorney says time is of the essence with women dying Opposing lawyer says cancer victims not treated ... alleging that asbestos-tainted talc in its iconic product has sickened users. Women ...

putting talcum powder users at risk. “Talc used regularly in the genital area was associated with a 33% increase in ovarian cancer risk overall.” – Journal of Epidemiology At least three separate ...

An NHS doctor has shared five common symptoms of ovarian cancer that often gets overlooked but that people should take more seriously. Ovarian cancer is a common type of cancer that affect the ...

took the stand at a trial in Houston on Wednesday as a paid expert witness for opponents of J&J’s $9 billion settlement plan to end cancer cases targeting its signature powder.